Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.

Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T.

Cancer Discov. 2011 Aug;1(3):236-47. doi: 10.1158/2159-8290.CD-11-0073. Epub 2011 Jun 16.

2.

The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma.

Berenson JR, Ma HM, Vescio R.

Semin Oncol. 2001 Dec;28(6):626-33. Review.

PMID:
11740821
3.

Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.

Zeligs KP, Neuman MK, Annunziata CM.

Clin Cancer Res. 2016 Sep 1;22(17):4302-8. doi: 10.1158/1078-0432.CCR-15-1374. Epub 2016 Jul 15. Review.

Supplemental Content

Support Center